Timber Creek Capital Management LLC Eli Lilly & CO Transaction History

Timber Creek Capital Management LLC

$335 Million
Q3 2024

A detailed history of Timber Creek Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Timber Creek Capital Management LLC holds 12,632 shares of LLY stock, worth $9.45 Million. This represents 3.35% of its overall portfolio holdings.

Number of Shares

12,632

Previous 12,546 0.69%

Holding current value

$9.45 Million

Previous $11.4 Million 1.47%

% of portfolio

3.35%

Previous 3.57%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $66,404 - $82,561	86 Added 0.69%	12,632 $11.2 Million
Q2 2024 Jul 18, 2024	SELL	$724.87 - $909.04 $8,698 - $10,908	-12 Reduced 0.1%	12,546 $11.4 Million
Q1 2024 Apr 03, 2024	SELL	$592.2 - $792.28 $1.21 Million - $1.62 Million	-2,041 Reduced 13.98%	12,558 $9.77 Million
Q4 2023 Jan 11, 2024	SELL	$525.19 - $619.13 $387,590 - $456,917	-738 Reduced 4.81%	14,599 $8.51 Million
Q3 2023 Oct 18, 2023	SELL	$434.7 - $599.3 $254,299 - $350,590	-585 Reduced 3.67%	15,337 $8.24 Million
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $1.31 Million - $1.76 Million	-3,748 Reduced 19.05%	15,922 $7.47 Million
Q1 2023 Apr 06, 2023	SELL	$310.63 - $364.82 $9,629 - $11,309	-31 Reduced 0.16%	19,670 $6.76 Million
Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $319,942 - $372,796	-995 Reduced 4.81%	19,701 $0
Q3 2022 Oct 12, 2022	SELL	$296.48 - $337.87 $76,788 - $87,508	-259 Reduced 1.24%	20,696 $6.69 Million
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $211,277 - $248,070	-758 Reduced 3.49%	20,955 $6.79 Million
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $587,194 - $729,733	-2,502 Reduced 10.33%	21,713 $6.22 Million
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $10,118 - $12,556	-45 Reduced 0.19%	24,215 $6.69 Million
Q3 2021 Oct 08, 2021	SELL	$221.6 - $272.71 $88,418 - $108,811	-399 Reduced 1.62%	24,260 $5.61 Million
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $734,296 - $949,807	4,067 Added 19.75%	24,659 $5.66 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $338,992 - $438,841	-2,063 Reduced 9.11%	20,592 $3.85 Million
Q4 2020 Jan 25, 2021	SELL	$130.46 - $172.63 $47,617 - $63,009	-365 Reduced 1.59%	22,655 $3.83 Million
Q3 2020 Oct 20, 2020	BUY	$146.22 - $169.13 $8,773 - $10,147	60 Added 0.26%	23,020 $3.41 Million
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $88,672 - $106,717	-650 Reduced 2.75%	22,960 $3.77 Million
Q1 2020 Apr 17, 2020	SELL	$119.05 - $147.35 $1.03 Million - $1.27 Million	-8,617 Reduced 26.74%	23,610 $3.28 Million
Q4 2019 Jan 30, 2020	SELL	$106.92 - $132.43 $167,650 - $207,650	-1,568 Reduced 4.64%	32,227 $4.24 Million
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $63,540 - $69,115	-595 Reduced 1.73%	33,795 $3.78 Million
Q2 2019 Aug 05, 2019	SELL	$110.79 - $129.32 $2,326 - $2,715	-21 Reduced 0.06%	34,390 $3.81 Million
Q1 2019 Apr 23, 2019	SELL	$111.31 - $131.02 $1.35 Million - $1.58 Million	-12,095 Reduced 26.01%	34,411 $4.47 Million
Q4 2018 Jan 30, 2019	SELL	$105.9 - $118.64 $1.25 Million - $1.4 Million	-11,785 Reduced 20.22%	46,506 $5.38 Million
Q3 2018 Oct 26, 2018	SELL	$85.86 - $107.31 $30,480 - $38,095	-355 Reduced 0.61%	58,291 $6.26 Million
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $82,134 - $94,264	-1,085 Reduced 1.82%	58,646 $5 Million
Q1 2018 Apr 30, 2018	BUY	$74.21 - $87.6 $17,068 - $20,148	230 Added 0.39%	59,731 $4.62 Million
Q4 2017 Jan 31, 2018	BUY	$81.94 - $87.89 $127,580 - $136,844	1,557 Added 2.69%	59,501 $5.03 Million
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $16,184 - $17,963	210 Added 0.36%	57,944 $4.96 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,123 Added 1.98%	57,734 $4.75 Million
Q2 2017 Aug 11, 2017	BUY	N/A	56,611	56,611 $4.76 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Timber Creek Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Timber Creek Capital Management LLC with notifications on news.

Account

Timber Creek Capital Management LLC Eli Lilly & CO Transaction History